We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Generex Biotechnology to Test Novel RNAi-Based Immune-Response Strategy in Cancer Patients

News   Mar 27, 2007

 
Generex Biotechnology to Test Novel RNAi-Based Immune-Response Strategy in Cancer Patients
 
 
 

RELATED ARTICLES

Cellular Drivers of Painful Childhood Food Allergy Characterized

News

An eight-year hunt for the cells that drive an extreme childhood food allergy (eosinophilic esophagitis, EoE) has identified a potential new way to treat the disease while also raising questions about a dietary supplement often taken to reduce bowel inflammation.

READ MORE

Blocking Protein’s Activity Restores Cognition in Old Mice

News

Brain cells called microglia serve as the brain’s garbage crew, scarfing up bits of cellular debris. But their underperformance in aging brains contributes to neurodegeneration. Could a strategy to restore this homeostasis be on the horizon?

READ MORE

Are We Responsible for Contacting Research Participants With New Genetic Findings?

News

The American Society of Human Genetics (ASHG), along with several co-signing organizations, issued a position statement today outlining whether, and to what extent, there is a responsibility to recontact genetic and genomic research participants when new findings emerge that suggest their genetic information should be interpreted differently, which would allow participants to benefit from current genomics advances.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE